Citadel Advisors
CRNX icon

Citadel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Citadel Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Buy
10,200
+200
+2% +$8.93K ﹤0.01% 9985
2025
Q4 		$466K Sell
10,000
-28,200
-74% -$1.26M ﹤0.01% 9196
2025
Q3 		$1.59M Buy
38,200
+23,500
+160% +$751K ﹤0.01% 6533
2025
Q2 		$423K Buy
14,700
+3,100
+27% +$95.7K ﹤0.01% 9020
2025
Q1 		$389K Buy
11,600
+4,000
+53% +$149K ﹤0.01% 9023
2024
Q4 		$389K Sell
7,600
-11,600
-60% -$649K ﹤0.01% 9117
2024
Q3 		$981K Buy
19,200
+15,700
+449% +$810K ﹤0.01% 6904
2024
Q2 		$157K Sell
3,500
-28,100
-89% -$1.3M ﹤0.01% 10278
2024
Q1 		$1.48M Buy
31,600
+21,300
+207% +$833K ﹤0.01% 6113
2023
Q4 		$366K Sell
10,300
-72,300
-88% -$2.22M ﹤0.01% 8741
2023
Q3 		$2.46M Buy
82,600
+78,300
+1,821% +$1.61M ﹤0.01% 4849
2023
Q2 		$77.5K Buy
4,300
+4,200
+4,200% +$83.8K ﹤0.01% 11279
2023
Q1 		$1.61K Sell
100
-1,000
-91% -$18.5K ﹤0.01% 14272
2022
Q4 		$20.1K Buy
+1,100
New +$19.4K ﹤0.01% 13140

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return